The genetic diversity of Helicobacter pylori virulence genes is not associated with gastric atrophy progression

Acta Medica Okayama

Volumn 67, Issue 2, 2013, Pages 93-98

  Kita, Masahide ^a   Yokota, Kenji ^b   Okada, Hiroyuki ^c   Take, Susumu ^a   Takenaka, Ryuta ^a   Kawahara, Yoshiro ^c   Oguma, Keiji ^d   Matsushita, Osamu ^d   Yamamoto, Kazuhide ^a  

^a Department of Gastroenterology and Hepatology ^*  (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chronic atrophic gastritis; Helicobacter pylori; Virulence genes

Indexed keywords

ADHESIN; BABA PROTEIN, HELICOBACTER PYLORI; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; ICEA2 PROTEIN, HELICOBACTER PYLORI; PICB PROTEIN, HELICOBACTER PYLORI; VACA PROTEIN, HELICOBACTER PYLORI; VIRULENCE FACTOR;

ARTICLE; ATROPHY; DISEASE COURSE; DUODENUM ULCER; FEMALE; GASTRITIS; GENETIC VARIABILITY; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; STOMACH TUMOR; STOMACH ULCER; VIRULENCE;

ADHESINS, BACTERIAL; ANTIGENS, BACTERIAL; ATROPHY; BACTERIAL PROTEINS; DISEASE PROGRESSION; DUODENAL ULCER; FEMALE; GASTRITIS; GENETIC VARIATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; STOMACH NEOPLASMS; STOMACH ULCER; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 84878748817     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Dixon MF: Pathology of gastritis and peptic ulceration. Helicobacter pylori Mobley HL, Mendz GL, and Hazell SL eds, ASM press Washington DC (2001) 459-470.
2. Forman D and Burley VJ: Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol (2006) 20: 633-649.
3. Peek RM Jr and Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer (2002) 2: 28-37.
4. Podzorski RP, Podzorski DS, Wuerth A and Tolia V: Analysis of the vacA, cagA, cagE, iceA, and babA2 genes in Helicobacter pylori from sixty-one pediatric patients from the Midwestern United States Diagn Microbiol Infect Dis (2003) 46: 83-88.
5. Huang JQ, Zheng GF, Sumanac K, Irvine EJ and Hunt RH: Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology (2003) 125: 1636-1644.
6. Kuipers EJ, Perez-Perez Gl, Meuwissen SG and Blaser MJ Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 87: 1777-1780.
7. Dhar SK, Soni RK, Das BK and Mukhopadhyay G: Molecular mechanism of action of major Helicobacter pylori virulence factors. Mol Cell Biochem (2003) 253: 207-215.
8. van Doom LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P. de Boer W and Quint W: Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology (1998) 115: 58-66.
9. PeekJrRM, Thompson SA, Donahue JP, Tham KT, Atherton JC Blaser MJ and Miller GG: Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1998) 110: 531-544.
10. Yamaoka Y, Kodama T, Gutierrez 0, Kim JG, Kashima K and Graham DY: Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 37: 2274-2279.
11. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Covacci A, Engstrand L and Boren T: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retag-ging. Science (1998) 279: 373-377.
12. Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, Naumann M and Meyer TF: Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol (2000) 2: 155-164
13. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ and Covacci A: c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol (2002)43: 971-980.
14. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W. Miehlke S, Classen M and Prinz C: Clinical relevance of the Helicobacter pylori gene for bloodgroup antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 96: 12778-12783.
15. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K. Oguma K, Okada H and Shiratori Y: The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol (2005) 100: 1037-1042.
16. Kimura K and Takemoto T: An endoscopic recognition of the atrophic border and prevent gastric cancer and its significance in chronic gastritis. Endoscopy (1969) 3: 87-97.
17. Sakaki N, ArakawaT, Katou H, Momma K, Egawa N, Kamisawa T, Yamada Y, Tu Y, Ishikawa C and Ishiwata J: Relationship between progression of gastric mucosal atrophy and Helicobacter pylori infection: Retrospective long-term ebdscopic follow-up study. J. Gastroenterol (1997) 32: 19-23.
18. Ito S, Azuma T, Murakita H, Hirai M, Miyaji H, Ito Y, Ohtaki Y. Yamazaki Y, Kuriyama M, Keida Y and Kohli Y: Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut (1996) 39: 8000-8006.
19. Sato K, Kimura K, Taniguchi Y, YoshidaY, Kihira K, Takimoto T Kawata H Saifuku K, Ido K, Takemoto T, Ota Y, Tada M, Karita M, Sakaki N and Hoshihara Y: Distribution of inflammation and atrophy in the stomach of He/fcotecfer-positive and -negative patients with chronic gastritis. Am J Gastroenterol (1996) 91: 963-969.
20. Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A: Sripa B, Tor-Udom S and Vilaichone RK: Prevalence of Helicobacter pylori VacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis (2008) 12: 30-36.
21. Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I Murata-Kamiya N, Azuma T and Hatakeyama M: EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem (2005) 280: 23130-2317.
22. The Eurohepygast Study Group: Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut (2002) 50: 779-785.
23. Lei Gao, Week MN, Michel A, Pawlita M and Brenner H: Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res (2009) 69: 2973-2980.
24. Holcombe C, Omotara BA, Eldridge J and Jones DM: H. pylori the most common bacterial infection in Africa: a random serologi-cal study. Am J Gastroenterol (1992) 87: 28-30
25. Miwa H, Go MF and Sato N: H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol (2002) 97: 1106-1112
26. Singh K and Ghoshal UC: Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol (2006) 12: 1346-1351.
27. Tsuji S: The 'Costa Rican enigma' of Helicobacter pylori CagA and gastric cancer. J Gastroenterol (2006) 41: 716-717.
28. Goh KL, Cheah PL, Md N, Quek KF and Parasakthi N: Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol (2007) 102: 1-5.
29. Ferreira RM, Machado JC, Leite M, Carneiro F and Figueiredo C The number of Helicobacter pylori CagA EPIYA C tyrosine phos-phorylation motifs influences the pattern of gastritis and the development of gastric carcinoma. Histopathology (2012) 60: 992-998
30. Rizzato C, Torres J, Plummer M, Muhoz N, Franceschi S. Camorlinga-Ponce M, Fuentes-Panana EM, Canzian F and Kato I Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention. PLoS One (2012) 7: e29605.